Descargar la presentación
La descarga está en progreso. Por favor, espere
1
Biosimilar regional performance
Lombardia MS: REMI: 52,8% BIO: 47,2% mar-15 apr-15 mag-15 giu-15 lug-15 ago-15 set-15 ott-15 nov-15 dic-15 gen-16 Feb-16 Mar-16 Apr-16 Mag-16 Giu-16 Lug-16 BIOSIMILAR 67 230 394 419 561 428 743 904 900 1.035 1.024 1.315 1.840 1.626 1.527 1.807 1.958 Remicade 3.500 2.952 2.983 2.712 3.336 2.350 2.878 2.306 2.801 2.237 2.144 2.284 2.565 2.141 2.014 2.045 2.194 Tot 3.567 3.182 3.377 3.131 3.897 2.778 3.621 3.210 3.701 3.272 3.168 3.599 4.405 3.767 3.541 3.852 4.152 Source: IMS IMFO
2
Infliximab regional performance
Lombardia mar-15 apr-15 mag-15 giu-15 lug-15 ago-15 set-15 ott-15 nov-15 dic-15 gen-16 Feb-16 Mar-16 Apr-16 Mag-16 Giu-16 Lug-16 BIOSIMILAR 67 230 394 419 561 428 743 904 900 1.035 1.024 1.315 1.840 1.626 1.527 1.807 1.958 Remicade 3.500 2.952 2.983 2.712 3.336 2.350 2.878 2.306 2.801 2.237 2.144 2.284 2.565 2.141 2.014 2.045 2.194 Tot 3.567 3.182 3.377 3.131 3.897 2.778 3.621 3.210 3.701 3.272 3.168 3.599 4.405 3.767 3.541 3.852 4.152 Source: IMS IMFO
Presentaciones similares
